These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7795587)

  • 1. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
    Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
    Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
    Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
    Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
    Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
    Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
    Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
    Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
    Klamt B; Koziell A; Poulat F; Wieacker P; Scambler P; Berta P; Gessler M
    Hum Mol Genet; 1998 Apr; 7(4):709-14. PubMed ID: 9499425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
    Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
    Zhai G; Iskandar M; Barilla K; Romaniuk PJ
    Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
    Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
    Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome.
    Perotti D; Mondini P; Giardini R; Ferrari A; Massimino M; Gambirasio F; Pierotti MA; Fossati-Bellani F; Radice P
    Ann Oncol; 1998 Jun; 9(6):627-31. PubMed ID: 9681076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.
    Denamur E; Bocquet N; Mougenot B; Da Silva F; Martinat L; Loirat C; Elion J; Bensman A; Ronco PM
    J Am Soc Nephrol; 1999 Oct; 10(10):2219-23. PubMed ID: 10505700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human sex-determining gene SRY is a direct target of WT1.
    Hossain A; Saunders GF
    J Biol Chem; 2001 May; 276(20):16817-23. PubMed ID: 11278460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
    Tajinda K; Carroll J; Roberts CT
    Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.